Accenture (ACN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
18 Dec, 2025Executive summary
Q1 FY26 revenue reached $18.7 billion, up 6% in USD and 5% in local currency, with strong growth in Asia Pacific and solid performance in Americas and EMEA.
New bookings totaled $20.9 billion, up 12% in USD and 10% in local currency, with 33 clients exceeding $100 million in bookings.
Adjusted operating margin expanded to 17.0%, while GAAP margin declined to 15.3% due to $308 million in business optimization costs.
Adjusted EPS grew 10% to $3.94, while GAAP EPS decreased 1% to $3.54 due to optimization costs.
$3.3 billion was returned to shareholders through dividends and share repurchases, an 83% YoY increase.
Financial highlights
Gross margin improved to 33.1% from 32.9% year-over-year.
Free cash flow was $1.5 billion; $3.3 billion returned to shareholders via buybacks and dividends.
Adjusted operating income was $3.18 billion, up from $2.95 billion YoY; GAAP operating income was $2.87 billion, down 3% YoY.
Cash and cash equivalents at quarter-end were $9.6 billion, down from $11.5 billion at the prior fiscal year-end.
Dividend per share was $1.63, with $1.0 billion paid in dividends during the quarter.
Outlook and guidance
FY26 revenue growth expected at 2%-5% in local currency (3%-6% excluding federal/AFS), with 1.5% inorganic contribution.
Adjusted operating margin for FY26 expected at 15.7%-15.9%, a 10-30 basis point expansion.
Adjusted EPS guidance for FY26 is $13.52-$13.90, or 5%-8% growth.
Free cash flow guidance for FY26 is $9.8 billion-$10.5 billion; at least $9.3 billion to be returned to shareholders.
Q2 FY26 revenue guidance: $17.35 billion-$18.0 billion, 1%-5% local currency growth.
Latest events from Accenture
- Q2 FY26 delivered record bookings, 8% revenue growth, and higher shareholder returns.ACN
Q2 202619 Mar 2026 - AI strategy is evolving rapidly, with ROI, specialization, and change management as top priorities.ACN
Fireside chat18 Mar 2026 - Q3 bookings hit $21.1B, GenAI surged, and FY24 guidance signals steady growth.ACN
Q3 20243 Feb 2026 - Record bookings, margin expansion, and robust FY25 outlook highlight strong momentum.ACN
Q4 202420 Jan 2026 - Q1 FY25 revenue up 9% to $17.7B; EPS, margin, and dividend rose, outlook raised.ACN
Q1 202510 Jan 2026 - Board recommends all proposals amid strong performance, governance, and ESG focus.ACN
Proxy Filing12 Dec 2025 - Board recommends approval of all director, compensation, auditor, and share issuance proposals.ACN
Proxy Filing12 Dec 2025 - Proxy covers 2025 AGM proposals, board refresh, pay-for-performance, and ESG leadership.ACN
Proxy Filing1 Dec 2025 - Fiscal 2024 saw record bookings, board refreshment, and major ESG progress, with all proposals recommended for approval.ACN
Proxy Filing1 Dec 2025